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Thoracoscopic Intradiscal 
Spine Fusion Using a Minimally 
Invasive Gene-Therapy Technique
BY K. DANIEL RIEW, MD, JUEREN LOU, MD, NEILL M. WRIGHT, MD, 
SU-LI CHENG, PHD, KYONGTAE T. BAE, MD, PHD, AND LOUIS V. AVIOLI, MD
Investigation performed at the Department of Orthopaedic Surgery, Barnes-Jewish Hospital
and Washington University School of Medicine, St. Louis, Missouri
Background: Gene therapy has been utilized to achieve posterior intertransverse process fusion in rodents. To our
knowledge, however, no one has previously reported on the use of this technique to achieve anterior spinal fusion in
mammals. The purpose of the present study was to determine if a gene-therapy technique can be utilized to achieve
anterior intradiscal fusion in pigs with use of minimally invasive techniques.
Methods: Mesenchymal stem cells were isolated from each of three pigs, expanded in culture, and transduced with an
adenovirus carrying either the gene for bone morphogenetic protein-2 (Adv-BMP2) or the control gene, β-galactosidase
(Adv-βgal). In vitro, assays were performed to detect BMP-2 expression as well as protein markers of bone formation. In
vivo, four thoracic disc spaces in each of three pigs were injected thoracoscopically with cells after 1 cm3 of the disc had
been removed. In each of the three pigs, two discs were injected with autologous mesenchymal stem cells trans-
duced with Adv-BMP2, the third disc was injected with cells transduced with Adv-βgal (control 1), and the fourth
disc served as the sham-operated control (control 2). The three animals were killed six weeks after the implanta-
tion. Computerized tomographic scanning was performed on two of the specimens, and histological examination
was performed on all specimens. The computerized tomographic scans and histological examinations were then in-
terpreted in a blinded fashion.
Results: In the in vitro study, a human BMP-2 protein band was detected in the medium of Adv-BMP2-transduced
stem cells but not in that of the control cells. The Adv-BMP2-transduced stem cells were associated with a fivefold in-
crease in alkaline phosphatase activity compared with the controls as well as with matrix mineralization and in-
creased protein expression of type-I collagen, osteopontin, and bone sialoprotein. In the in vivo study, radiographic
examination demonstrated anterior spinal fusion in all six disc spaces that had been treated with implantation of Adv-
BMP2-transduced stem cells. In contrast, the six control disc spaces had little or no intervening bone. Histological ex-
amination demonstrated bridging bone from end plate to end plate in all six disc spaces that had been treated with
implantation of Adv-BMP2-transduced stem cells. The six control disc spaces had no bridging bone.
Conclusion: The Adv-BMP2-transduced mesenchymal stem cells produced BMP-2 protein. Further, the cells differen-
tiated into osteoblasts and induced anterior spinal fusion in six of six disc spaces in this pig model. Although many
technical and practical challenges remain, the results of the present study suggest that it may eventually be possible
to use similar techniques to achieve anterior spinal fusion in humans.
number of experiments have suggested that bone mor-
phogenetic protein (BMP) may be used to enhance
bone fusion in the posterior part of the spine and per-
haps even to act as a bone substitute1,2. In a number of recent
studies, gene-therapy techniques have been used as an alterna-
tive to BMP to achieve bone formation in various animal
models3-5. To date, we are aware of only a few studies in which
either BMP or gene therapy has been used to achieve anterior
spinal fusion without the use of any bone or metallic im-
plants6,7. The current approach to anterior spinal fusion in-
volves removal of the disc followed by placement of bone in
the intradiscal space. The use of autograft carries with it the
morbidity of a second procedure, whereas the use of allograft
may be associated with a decreased fusion rate. The purpose
of the present study was to determine if implantation of mes-
enchymal stem cells that have been transduced with an aden-
ovirus carrying a gene for BMP-2 could induce spinal fusion
in pigs with use of minimally invasive means.
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Materials and Methods
Generation of Recombinant Adenoviral Vector 
Carrying the Human BMP-2 or β-Galactosidase Gene
he recombinant adenovirus carrying the human BMP-2
gene (Adv-BMP2) was constructed in our laboratory as pre-
viously described4,5,8. Adenovirus carrying the β-galactosidase
gene (Adv-βgal) served as a control in our experiments and
was generated in the same fashion with use of the gene encod-
ing β-galactosidase in place of the BMP-2 gene.
Harvest and Culture of Pig Bone Marrow 
Mesenchymal Stem Cells 
Pig ribs were harvested with use of sterile surgical techniques, and
mesenchymal stem cells were isolated from the rib marrow. Three
adult male pigs were used for these experiments. These animals
weighed 56, 65, and 68 kg at the time of the first operation. The
animals were five to six months old at the time of the rib harvest
and seven to eight months old at the time of the thoracoscopic
surgery. Approximately 8 cm of each rib was resected and placed
in sterile phosphate-buffered saline solution. The pigs were kept
alive for the second part of the study, in which the cells were im-
planted thoracoscopically into the disc spaces. The mesenchymal
stem cell suspension was prepared as previously reported8.
Cell Cultures
Pig bone-marrow stromal cells were isolated from the ribs as
described previously5,9. Briefly, the ribs were cleaned of any ex-
traneous tissue and then were split. Bone-marrow cells were ob-
tained by gently flushing the marrow cavity with α-minimum
essential medium Eagle (αMEM). The cells were purified
through a Histopaque-1077 density gradient and were allowed
to adhere to culture flasks for one week. Nonadherent cells were
removed, and adherent bone-marrow stromal cells, which rep-
resented relatively immature preosteoblastic cells5,9, were al-
lowed to grow to confluency in αMEM supplemented with 10%
heat-inactivated fetal bovine serum (growth medium).
Recombinant Adenovirus Transduction 
of Pig Mesenchymal Stem Cells
We subcultured the cells three times to increase the number of
cells. When the third subculture produced enough cells to
cover 90% of the culture dish, the cells were divided into
thirds. One third each was incubated with ADV-BMP2 or
ADV-βgal at fifty plaque formation units (pfu)/cell. The final
third was left alone in culture overnight. After removal of
transduction medium, the cells were further cultured in the
growth medium for seven days, with a medium change on the
third or fourth day. The cells were harvested for analysis of
bone-matrix proteins or were resuspended in a collagen solu-
tion at 3 × 106 cells/mL for autologous implantation at the site
of anterior spinal arthrodesis. The conditioned medium was
also harvested for examination of BMP-2 secretion.
Biochemical Assays
Immunostaining was performed to detect the presence of BMP-
2 in the cell layer, and Western blot analysis was performed to
detect secreted human BMP-25,8. Molecular weight markers
were utilized to confirm the identification of the bone-matrix
proteins.
Thoracoscopic Implantation of Cells into Pig Disc Spaces




Western blot analysis was performed for the detection of secreted 
BMP-2. The specific band at 20.7 kDa was detected only in the con-
ditioned medium of cells transduced with Adv-BMP2. MSC = mesen-
chymal stem cells.
Von Kossa staining demon-
strated matrix mineralization in 
only the Adv-BMP2-transduced 
cells. MSC = mesenchymal stem 
cells.
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Under thoracoscopic guidance, the left anterolateral aspect of
each disc space was identified and the overlying parietal pleura
was incised. With use of a combination of sharp and blunt tho-
racoscopic instruments, alternating disc spaces were entered. A
minimal amount (1 cm3) of disc material was removed to pro-
vide a space for cell implantation. Under thoracoscopic guid-
ance, cells transduced with either the control (β-gal) or the
experimental (BMP-2) adenovirus were injected into the disc
space with use of an 18-gauge spinal needle inserted through
the thoracoscopic ports. Each disc space received approximately
5 × 107 transduced autologous mesenchymal stem cells. Care
was taken to avoid cross-contamination of either the disc space
or the overlying tissue. In each of the three pigs, two discs were
injected with the BMP-2 experimental cells, one disc was in-
jected with the β-gal control cells (control 1), and one disc
served as the sham-operated control (control 2). The pigs re-
mained healthy until they were killed at six weeks. There were
no obvious deleterious effects from the adenoviral vectors. The
spines were harvested six weeks after the autologous implanta-
tion of mesenchymal stem cells.
Plain Radiography
After the spine had been harvested from the first pig, a plain ra-
diograph was made. Because we had difficulty ascertaining
whether a fusion had occurred, we elected to proceed directly to
histological examination of this specimen. After consulting with
our radiologist, we elected to forego plain radiographs and used
computerized tomographic scans for the next two pigs.
Computed Tomography 
The spines harvested from the other two pigs were evaluated
with computed tomography. Reformatted images of the
computed tomographic scans were evaluated qualitatively
for the presence of intradiscal bone formation. In addition,
we measured the x-ray attenuation of the computed tomog-
raphy scans (in Hounsfield units) to quantify bone forma-
tion by placing circular regions of interest over the disc
spaces and the cortical end plates. Because bone reduces the
intensity of the x-ray beam far more than soft tissue does,
the computed tomography attenuation value increases with
bone formation. The computed tomographic scans were in-
terpreted by a radiologist who was blinded to the protocol of
cell injection.
Twelve measurements were made for each pig, with
three measurements (two from the disc and one from the end
plate) being made for each of the four discs (the two treated
with BMP-2, the one treated with β-gal, and the one treated
with the sham operation).
Fig. 3
Sagittal reformation of computed tomographic images of the 
spines of two pigs. Bone formation was clearly visualized in 
the fused (upper) disc spaces but not in the control (lower) 
disc spaces. The attenuation values in the fused disc spaces 
were higher than those in the control disc spaces, quantita-
tively confirming bone formation.
Fig. 4
Photomicrographs demonstrating bone from one 
end plate to the next in the Adv-BMP2-treated disc 
(right) but not in the control disc (left) (hematoxylin 
and eosin).
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Histological Evaluation
Following the radiographic or computed tomographic examina-
tion, the specimens were fixed in neutral formalin. The experi-
mental disc spaces were isolated and treated with Decalcifier I
(Surgipath Medical Industries, Richmond, Illinois) overnight.
The samples were then treated with standard procedures for em-
bedding, incision, and staining with hematoxylin.
Results
esenchymal stem cells transduced with Adv-BMP2 were ca-
pable of overexpressing BMP-2 protein seven days after
transduction. BMP-2 expression was detectable in >80% of these
cells on immunostaining. Cells transduced with Adv-BMP2 se-
creted human BMP-2 into the conditioned medium, whereas no
BMP-2 secretion was detected in the conditioned medium of cells
transduced with Adv-βgal or that of untreated cells (Fig. 1).
Moreover, the BMP-2 in the conditioned medium of cells trans-
duced with Adv-BMP2 had a molecular weight of 21 kDa, consis-
tent with the size of mature BMP-2. The alkaline phosphatase
activity of cells transduced with Adv-BMP2 showed a dramatic
increase compared with the activity of control cells. Seven days af-
ter transduction, Adv-BMP2-transduced cells had as much as five
times the alkaline phosphatase activity of control cells.
The level of type-I collagen in Adv-BMP2-transduced
cells was greatly increased compared with the levels in Adv-
βgal-transduced cells and untreated cells. In addition, os-
teopontin and bone sialoprotein expression was increased in
Adv-BMP2-transduced cells. Matrix mineralization occurred in
Adv-BMP2-transduced cells by eighteen days after transduc-
tion, whereas the matrices of the Adv-βgal-transduced cells and
the untransduced cells remained unmineralized (Fig. 2).
Computed Tomographic Assessment
Sagittally reconstructed computed tomographic images clearly
demonstrated increased bone formation in the disc spaces in-
jected with Adv-BMP2-transduced cells compared with the
control disc spaces (Fig. 3). The attenuation measurements in
these disc spaces were much higher than those in the control
disc spaces and were close to those in the area of the cortical end
plates. The mean value of the attenuation was 562 Hounsfield
units (HU) for the experimental discs compared with 186 HU
for the controls (p < 0.001). The disc alignment was neutral.
M
Fig. 5
Low-power photomicrographs of the control, Adv-βgal-treated, and Adv-BMP2-treated discs for the three pigs. Note that only the Adv-BMP-
treated discs demonstrate bone formation.

 TH E JO U R NA L OF BONE & JOINT SURGER Y ·  JBJS .ORG
VO LU M E 85-A ·  NU M B ER 5 ·  MAY 2003
THOR A CO SCOPIC IN T R A D I SC A L SPINE FUSION US I N G A 
MINIMAL LY INVA S IVE GENE-TH E R A PY TE CH N I QU E
Histological Assessment
Solid bone formed across all six of the disc spaces that had been
treated with Adv-BMP2. The bone bridged the superior and in-
ferior end plates of each of the disc spaces. In contrast, none of
the three disc spaces that had received Adv-βgal and none of the
three sham-operated disc spaces had any bone formation (Figs.
4, 5, and 6).
Discussion
n the present study of anterior spinal fusion with use of
gene therapy, we used minimally invasive means and no in-
strumentation. We observed contiguous bone formation from
one end plate to the adjacent end plate in all six disc spaces
(two discs in each of three pigs) that had been treated with im-
plantation of Adv-BMP2-transduced mesenchymal stem cells.
There was no new-bone formation in any of the control discs
that had been treated with the sham operation (three discs) or
with implantation of Adv-βgal-transduced mesenchymal stem
cells (three discs). These findings suggest that when mesen-
chymal stem cells carrying the gene for BMP-2 are placed into
a minimally disrupted intradiscal space, they are capable of
producing end plate-to-end plate bone formation.I
Fig. 6
Medium-power photomicrographs of the control, Adv-βgal-treated, and Adv-BMP2-treated 
discs for the three pigs. The arrowheads point to the end plates of each disc, and the as-
terisks show the newly formed bone.
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The intervertebral disc is unique in that it is relatively
avascular and acellular. We thought that in such an environ-
ment it might be advantageous to add mesenchymal stem cells
that were capable of differentiating into an osteoblastic lineage.
Previously, we performed a pilot experiment in which we dis-
rupted the intradiscal space and injected BMP-2 (unpublished
data). Because we were unable to demonstrate any new-bone
formation, we abandoned this technique. In contradistinction
to the findings that have been noted following injections of
BMP-2 into muscle and other tissues that are cellular and vascu-
lar, we believe that our failure to demonstrate any new-bone
formation might have been due to the relative avascularity and
acellularity of the intradiscal space. This failure might also have
been due to an inadequate dosage of drug. Muschik et al. were
able to induce anterior spinal fusion with use of bovine mor-
phogenetic protein in rabbits7. While other authors have
achieved anterior spinal fusion with use of bone morphogenetic
proteins, they also used either metallic or bone implants6,10,11.
Because the current investigation was a limited pilot
study to determine if our techniques could be successfully used
to produce intradiscal bone, we did not make adequate provi-
sions to perform biomechanical testing. Further experiments
that will include biomechanical testing are being planned. In
addition, there was no attempt to quantitate the actual amount
of bone formation. We believe that because blinded radio-
graphic and histological evaluators were able to determine eas-
ily and conclusively that end plate-to-end plate bone formation
was present in the experimental discs but not in the control
discs, actual quantification was unnecessary.
Whether the results that we obtained in this porcine
model might be extrapolated to humans is unknown. Although
the posterior intertransverse process fusion rate in the rabbit
model appears to be similar to that in humans, the rate in the
porcine model has never been compared with that in humans, to
our knowledge. On the other hand, the porcine model has been
widely utilized for studies on endoscopic procedures because of
its anatomic similarity to humans12-14. While our results suggest
the eventual possibility of similar results in humans, there are
numerous technical and practical hurdles that must first be over-
come. Not the least of these is that the issue of safety surround-
ing the use of viral vectors must first be adequately addressed.
In summary, all six discs that had been treated with im-
plantation of adenovirally transduced mesenchymal stem cells
carrying the gene for BMP-2 demonstrated fusion whereas
all six control discs remained unfused. Although we utilized
thoracoscopic techniques to perform these operations, we be-
lieve that our techniques could be modified to achieve similar
results with use of fluoroscopically controlled percutaneous
injections. 
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